Toxic Effect Study of Methanol Extract of Terminalia Glaucesens Leaves Following Single or Short-Term Repetitive Oral Administration in Swiss Mice
American Journal of BioScience
Volume 1, Issue 4, November 2013, Pages: 85-90
Received: Dec. 19, 2013;
Published: Jan. 10, 2014
Views 3084 Downloads 204
Tano Konan Dominique, Dept. of Parasitology-Mycology, UFR des Sciences Pharmaceutiques et Biologiques, Abidjan, Côte d’Ivoire
Kouadio James Halbin, Dept. of Biochemistry and Microbiology, UFR Agroforesterie, University of J. Lorougnon GUEDE, Daloa, Côte d’Ivoire
Yavo William, Dept. of Parasitology-Mycology, UFR des Sciences Pharmaceutiques et Biologiques, Abidjan, Côte d’Ivoire
Djaman Alico Joseph, Dept. of Biochemistry and Pharmacology, UFR Bioscience, University of F.H. BOIGNY, Abidjan, Côte d’Ivoire
Menan Eby Ignace Hervé, Dept. of Parasitology-Mycology, UFR des Sciences Pharmaceutiques et Biologiques, Abidjan, Côte d’Ivoire
The uses of different parts of the plant Terminalia glaucescens in traditional medicine is well known in some African countries. Thus, the methanol or aqueous extract of plant leaves or roots was pharmacologically studied for its benefit effects in malaria, diabetes, cardiac and hepatic diseases. However, there is no investigation in probable adverse effect in order to determine safety dose for human users. In consequence, the aim of the present study was to evaluate both acute and sub-acute toxicity of methanol extract of Terminalia glaucescens leaves in Swiss mice following single oral and repetitive administration. As results, the oral LD50 of the preparation in Swiss mice was found to be greater than 2500 mg/kg body weight (bw). In the repetitive toxicity study, Swiss mice (10/sex/group) were administered via oral gavage 0 (control), 13.90 (traditional therapeutic dose for malaria) and high dose 1390 mg/kg bw/day of the plant leaves extract for 15 days. Administration of the plant leaves preparation did not result in any toxicologically significant treatment-related changes in clinical (including behavioral) observations. Interestingly, benefit effects have been observed in body weights for therapeutic dose (13.90 mg/kg bw/day) and some organs weight such as kidney and spleen (for females) were increased. Hepatoprotection and hypolipidemic actions have been observed with serum ALT and lipids (total cholesterol and triglycerides) decrease in mice having received therapeutic dose (13.90 mg/kg bw/day). In addition, benefit effect has been observed in hemoglobin amount in animal treated by therapeutic dose. In parallel, precocious adverse effects have been observed with high dose of 1390 mg/kg bw/day in body weights and hemoglobin amounts and leukocytes cells number which were decreased when compared to control (p<0.01). This leucopenia was not linked to lymphocytes because they stayed unchanged. Probable neutropenia or myelotoxic effect could be the etiology of such leucopenia. Based on the results of this study, the No Observed-Adverse-Effect Level (NOAEL) for methanol extract of Terminalia glaucescens leaves in Swiss mice could be near but under 1390mg/kg bw/ day.
Tano Konan Dominique,
Kouadio James Halbin,
Djaman Alico Joseph,
Menan Eby Ignace Hervé,
Toxic Effect Study of Methanol Extract of Terminalia Glaucesens Leaves Following Single or Short-Term Repetitive Oral Administration in Swiss Mice, American Journal of BioScience.
Vol. 1, No. 4,
2013, pp. 85-90.
E. Nasir and S. I. Ali, "Flora of West Pakistan", No. 122, vol. 1. Ferozsons Karachi, 1978.
A. Dermarderosian, "The Review of Natural Products I", Facts and Comparison, Missouri, pp. 637, 2002.
J. Koudou, G. Roblot and R. Wylde, "Tannin Constituents of Terminalia glaucescens", Planta Med. 1995, vol. 61, pp. 490.
E. O. Sote and M. Wilson, "In-vitro antibacterial effects of extracts of Nigerian tooth-cleaning sticks on periodontopathic bacteria", Afr. Dent. J., 1995, vol. 9, pp.15-19.
A. Mustofa, F. Valentin, Y. Benoit-Vical, D. Pelissier, M. Kone-Bamba and J. Mallie, "Antiplasmodial activity of plant extracts used in west African traditional medicine", Ethnopharmacol., 2000, vol. 73, pp.145-151.
Y. H. Choi, J. M. Pezzuto, A. D. Kinghorn and N. R. Farnsworth, "Ellagic acid derivatives of Agrostistachys hookeri", Planta Med., 1988, vol. 54, pp.511-513.
S. Terashima, M. Schimizu, H. Nakayama, M. Ishikura, A. Suzui and N. Morita, "Studies on aldose reductase inhibitors from medicinal plant of "sinfito," Potentilla candicans, and further synthesis of their related compounds", Chem. Pharm. Bull., 1990, Vol. 38, pp. 2733-2736.
D. E. U. Ekong and O. G. Idemudia, "Constituents of some West African members of the genus Terminalia", J. Chem. Soc. C., 1967, pp. 863-864.
E.N. Bum, S. Soudi, E.R. Ayissi, C. Dong, N.H. Lakoulo, F. Maidawa, P.F.E. Seke, L.D. Nanga, G.S. Taiwe, T. Dimo, N. Njikam, A. Rakotonirina, S.V. Rakotonirina, A. Kamanyi "Anxiolytic Activity Evaluation of Four Medicinal Plants from Cameroon" African Journal of Traditional, Complementary and Alternative Medicines, 2011, Vol 8, pp. 130-139.
O.O Ayepola, "Evaluation of the Antimicrobial Activity of Root and Leaf Extracts of Terminalia glaucescens" Advances in Natural and Applied Sciences, 2009, vol. 3, pp. 188-191.
G. Ingabire, H.K. Koumaglo, C. De Souza, C.K. Dotse, K. Anani, J. Kabera, et al. Antimicrobial activity and preliminary phytochemical screening of Turraea heterophylla and Terminalia glaucescens used in Togo ethnomedecine to treat common infections. Planta Med., 2007, vol. 73, pp. 986-996.
A.M. Oloyede, A. O. Efem, I. K. Ejikeme, "Evaluation of the antimicrobial and phytochemical properties of a herbal preparation", Nature & Science, 2012, Vol. 10, pp. 43-48.
Atta-ur-Rahman, Seema Zareen, M. Iqbal Choudhary, M. Nadeem Akhtar, Shahida Shujaat, and F. N. Ngounou, "Some Chemical Constituents of Terminalia glaucescens and their Enzymes Inhibition Activity", Z. Naturforsch., 2005, vol. 60, pp. 347 – 350.
G. B. Sabas Nya Njomen, R. Kamgang, J.L.E. Oyono and N. Njikam "Antioxidant potential of the methanol–methylene chloride extract of Terminalia glaucescens leaves on mice liver in streptozotocin-induced stress", Indian J Pharmacol., 2008, vol. 40, pp. 266–270.
H.S. Kim, S.J. Kwack, E.S. Han, T.S. Kang, S.H. Kim, S.Y. Han, "Induction of apoptosis and CYP4A1 expression in Sprague-Dawley rats exposed to low doses of perfluorooctane sulfonate" The Journal of Toxicological Sciences, 2011, Vol. 36, pp. 201-210.
M.S. Kaiya and S.M.Thansborg, "Effect of Acacia nilotica and Acacia karoo diets on haemonchus contortus in goats", Vet Parasitol, 2003, vol.115, pp. 265-72.
W. Vincent "The Etiology and Management of Leukopenia", Can Fam Physician, 1984, vol.30, pp. 1835–1839.
J.F. Kiraly and M.S. Wheby, "Bone marrow necrosis", The American Journal of Medicine, 1976, Vol. 60, pp. 361-368.
Semra Paydas, Melek Ergin, Fikri Baslamisli, Sinan Yavuz, Suzan Zorludemir, Berksoy Sahin, Filiz A. Bolat Bone marrow necrosis: Clinicopathologic analysis of 20 cases and review of the literature American Journal of Hematology, 2002, Vol. 70, pp. 300–305.
M. W. Yeh, P. H. G. Ituarte, H. C. Zhou, S. Nishimoto, I.-L. Amy Liu, A. Harari, P. I. Haigh and A. L. Adams, "Incidence and Prevalence of Primary Hyperparathyroidism in a Racially Mixed Population", Journal of Clinical Endocrinology & Metabolism, 2013, vol.10, pp. 4022.